Follow us on Facebook

Walaw

Health

Morocco Aims for Pharmaceutical Self-Sufficiency, Targets 70% Local Production

Wednesday 17 July 2024 - 14:00

Zoom

In a significant move towards pharmaceutical autonomy, Morocco is poised to dramatically increase its domestic medication production, according to Health and Social Protection Minister Khalid Ait Taleb. Speaking at a parliamentary session in Rabat on Tuesday, Ait Taleb unveiled ambitious plans to manufacture up to 70% of the nation's medication requirements locally, including generic drugs.

Addressing the National Rally of Independents (RNI) group, Ait Taleb highlighted Morocco's advanced pharmaceutical sector and the presence of highly qualified companies capable of meeting the country's medication demands. This initiative is part of a broader strategy to bolster Morocco's health security and reduce dependence on imported pharmaceuticals.

The minister outlined several key components of this strategy:

1. Decentralization of pharmaceutical industries: Agreements have been signed to establish production facilities across various cities, moving beyond traditional hubs like Casablanca and Berrechid.

2. State-of-the-art vaccine manufacturing: Following directives from King Mohammed VI, a cutting-edge facility is being developed with an annual capacity of 144 million doses – far exceeding Morocco's yearly requirement of 22 million doses. This excess capacity positions Morocco as a potential vaccine exporter to other African nations.

3. Strategic medication reserves: Ait Taleb emphasized the importance of maintaining a stockpile of essential medications to manage potential health crises effectively.

4. Addressing high medication costs: The ministry has implemented a new governance framework to tackle the issue of expensive medications, particularly for cancer treatments. An agreement between the Moroccan Agency for Medicines and Health Products and various partners aims to produce affordable cancer drugs locally.

This comprehensive approach not only seeks to secure Morocco's pharmaceutical needs but also envisions the country playing a pivotal role in regional health security. By potentially supporting neighboring countries, Morocco is positioning itself as a key player in African healthcare.

The minister's announcement reflects a growing trend among nations to strengthen their pharmaceutical independence in the wake of global supply chain disruptions. Morocco's initiative, if successful, could serve as a model for other countries seeking to enhance their health sovereignty.

As this ambitious plan unfolds, it will be crucial to monitor its implementation and impact on both domestic healthcare accessibility and Morocco's position in the regional pharmaceutical landscape. The coming years will reveal whether this bold vision can transform Morocco into a self-sufficient pharmaceutical powerhouse capable of meeting its own needs and supporting its neighbors.